Amgen Inc (NASDAQ:AMGN)
| 241.53 Delayed Data As of Jul 30 |  -0.93 / -0.38%Today’s Change | 210.28 Today|||52-Week Range 276.69 | +5.05% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 242.46 |
| Today’s open | 242.65 |
| Day’s range | 240.68 - 243.11 |
| Volume | 136,496 |
| Average volume (3 months) | 2,474,577 |
| Market cap | $138.8B |
Data as of 4:00pm ET, 07/30/2021
Growth & Valuation
| Earnings growth (last year) | -4.37% |
| Earnings growth (this year) | -1.43% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +8.53% |
| P/E ratio | 20.0 |
| Price/Sales | 5.37 |
| Price/Book | 14.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | +7.95 | +2.30% |
| GILDGilead Sciences | -1.54 | -2.21% |
| ILMNIllumina Inc | +4.13 | +0.84% |
| BIIBBiogen | -2.07 | -0.63% |
Data as of 5:41pm ET, 07/30/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | $4.09 |
| Annual revenue (last year) | $25.2B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 28.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
